Endocrine Unit, Niguarda Ca'Granda Hospital, Piazza Ospedale Maggiore 3, 20162, Milan, Italy.
Pituitary. 2012 Jun;15(2):193-201. doi: 10.1007/s11102-011-0306-3.
Patients with Cushing's syndrome (CS) develop osteopenia-osteoporosis. The present study evaluates the recovery of bone mass within 2 years after remission of hypercortisolism and in long term follow up, an issue rarely addressed. Twenty patients (6M, 14F, 3 post-menopausal, 15-64 years old), 15 with Cushing's disease, 2 with ectopic ACTH syndrome, 3 with ACTH-independent CS were studied. BMD, T and Z scores at lumbar spine and proximal femur were assessed by dual-energy X-ray absorptiometry before and 7-33 months after treatment of hypercortisolism. Five patients were treated with bisphosphonates. Four patients had hypogonadism and 4 GH-deficiency. At baseline all patients showed osteopenia/osteoporosis and the spine appeared more damaged than the femur; femur BMD was positively related with body mass index (BMI). No correlations were observed between spine and femur bone parameters and duration of disease or severity of hypercortisolism. Bone parameters did not differ in patients with or without GH or other pituitary deficiencies. After cure of hypercortisolism a significant improvement in spine BMD, Z and T scores and in femur Z and T scores was observed with normalization in 3 patients; there was no significant difference in percent improvement between femur and spine. The increase in bone parameters at spine and femur was independent from values at baseline. The percent increase in spine T and Z scores was positively related with time elapsed since cure. Bisphosphonates did not influence the recovery of bone mineralization. In long term follow up, after a median period of 7 years a further improvement in bone density was observed in 100% of patients at spine and in 9/11 at femur, although 8/11 patients still had femoral and/or vertebral T score in the range of osteopenia/osteoporosis. Spontaneous improvement of osteoporosis after cure of hypercortisolism occurs both at spine and femur, is independent from basal conditions and not affected by bisphosphonates. The improvement at spine depends on time since cure.
库欣综合征(CS)患者会出现骨质疏松症。本研究评估了皮质醇过多症缓解后 2 年内骨量的恢复情况,并在长期随访中探讨了这一很少被关注的问题。研究共纳入 20 名患者(6 名男性,14 名女性,3 名绝经后,年龄 15-64 岁),其中 15 名患有库欣病,2 名患有异位 ACTH 综合征,3 名患有 ACTH 非依赖性 CS。所有患者均通过双能 X 线吸收法测定腰椎和股骨近端的骨密度、T 值和 Z 值,分别在皮质醇过多症治疗前和治疗后 7-33 个月进行。5 名患者接受了双膦酸盐治疗。4 名患者存在性腺功能减退症,4 名患者存在生长激素缺乏症。基线时,所有患者均存在骨质疏松/骨量减少,且脊柱骨密度较股骨更差;股骨骨密度与体重指数(BMI)呈正相关。脊柱和股骨骨参数与疾病持续时间或皮质醇过多症的严重程度之间无相关性。无 GH 或其他垂体功能减退的患者之间,骨参数无差异。皮质醇过多症治愈后,脊柱 BMD、Z 评分和 T 评分以及股骨 Z 评分和 T 评分均显著改善,3 名患者恢复正常;股骨和脊柱的改善百分比无显著差异。脊柱和股骨的骨参数增加与基线值无关。脊柱 T 评分和 Z 评分的增加百分比与治愈后时间呈正相关。双膦酸盐治疗不影响骨矿化的恢复。在长期随访中,中位随访 7 年后,100%的患者脊柱骨密度进一步增加,9/11 名患者股骨骨密度增加,尽管 8/11 名患者的股骨和/或椎体 T 评分仍处于骨质疏松/骨量减少的范围内。皮质醇过多症治愈后,骨质疏松症自发改善发生在脊柱和股骨,与基础情况无关,不受双膦酸盐影响。脊柱的改善取决于治愈后的时间。